ICD-10-CM Billable Code

G71.038

Other limb girdle muscular dystrophy

Clinical Classification Guidelines

Inclusion Terms

  • LGMD R22 collagen 6-related
  • Other autosomal recessive limb girdle muscular dystrophy

Medical Intelligence & Overview

Other Limb Girdle Muscular Dystrophy, classified under ICD-10 code G71.038, is a group of genetic disorders characterized by progressive weakness and degeneration of the muscles surrounding the hips and shoulders. This condition is part of the broader category known as limb girdle muscular dystrophies (LGMD), with specific subtypes like LGMD R22 related to collagen 6. These muscular dystrophies vary in severity and age of onset, but they generally lead to increasing muscle weakness over time, impacting mobility and daily functioning.

Causes & Symptoms

Clinical Causes: Mutations in genes responsible for producing proteins essential for muscle integrity, such as collagen 6 in collagen 6-related LGMD Inheritance patterns primarily include autosomal recessive mechanisms, meaning two copies of the mutated gene are necessary for the disease to manifest Genetic variability contributing to different subtypes within limb girdle muscular dystrophies, including variations in collagen 6-related forms

Key Symptoms: Progressive weakness of the shoulder and hip muscles Difficulty rising from a seated position or climbing stairs Muscle wasting and thinning in affected areas Potential contractures or joint stiffness over time In some cases, involvement of respiratory muscles leading to breathing difficulties Genetic predisposition may result in symptoms appearing in childhood, adolescence, or adulthood depending on the subtype

Diagnostic & Treatment

Diagnosis Path: Diagnosis of G71.038 involves a combination of clinical examination, family medical history review, and specialized tests such as: - Blood tests measuring muscle enzymes like creatine kinase (CK) - Electromyography (EMG) to assess muscle electrical activity - Muscle biopsy to examine muscle tissue for characteristic changes - Genetic testing to identify mutations in specific genes associated with collagen 6 or other related proteins - Imaging techniques like MRI may be used to evaluate muscle involvement and severity These assessments help differentiate this subtype from other forms of muscular dystrophy and guide management strategies.

Treatment Protocols: Currently, there is no cure for other limb girdle muscular dystrophy. Treatment focuses on managing symptoms, maintaining muscle strength, and improving quality of life. Approaches include: - Physical therapy to enhance muscle function and prevent contractures - Occupational therapy to assist with daily activities - Use of assistive devices such as braces or wheelchairs as mobility declines - Respiratory support if breathing muscles are affected - Regular monitoring for cardiac or respiratory complications - Management of pain or joint stiffness Research into genetic therapies and other innovative treatments continues, offering hope for future advancements. Supportive care and adaptive strategies play a vital role in helping individuals adapt to the progressive nature of the disease.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G71.038 a billable ICD-10 code?
Yes, G71.038 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G71.038?
Clinical documentation must specify the nature of Other limb girdle muscular dystrophy and any associated comorbidities for accurate reporting.

Cite this Clinical Reference